Sign In
Buy MRVI
$4.84
+0.0100 (+0.207%)
At Close: Jun 03, 2026
BOSTON, MA / ACCESS Newswire / February 26, 2025 / Block & Leviton is investigating Maravai Lifesciences Holdings, Inc (Nasdaq:MRVI) for potential securities law violations. Investors who have lost mo
Maravai LifeSciences Securities Fraud Investigation: Investors Urged to Contact Award-Winning Firm, Gibbs Law Group LLP
09:13pm, Tuesday, 25'th Feb 2025
OAKLAND, Calif.--(BUSINESS WIRE)---- $MRVI #MRVI--Gibbs Law Group announces a legal investigation on behalf of Maravai LifeSciences investors.
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) investors
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) on behalf of invest
PHILADELPHIA, PA / ACCESS Newswire / February 25, 2025 / Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of Maravai LifeSciences Holdings, Inc. ("Maravai LifeSciences," "Ma
BOSTON, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Maravai Lifesciences Holdings, Inc (Nasdaq: MRVI) for potential securities law violations. Investors who have lost money in t
Maravai LifeSciences Postpones its Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
06:00am, Tuesday, 25'th Feb 2025
SAN DIEGO, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators
Maravai LifeSciences Completes Acquisition of the DNA and RNA Business of Officinae Bio
08:00am, Monday, 24'th Feb 2025
SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today that it has comple
TriLink BioTechnologies® and Aldevron Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
04:01pm, Tuesday, 04'th Feb 2025
SAN DIEGO--(BUSINESS WIRE)--TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has signed a non-exclusive L
TriLink BioTechnologies® Partners with Avantor® to Expand Nucleic Acid Solutions in Europe
06:00am, Monday, 03'rd Feb 2025
SAN DIEGO--(BUSINESS WIRE)--TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has partnered with, Avantor,
Maravai LifeSciences Announces Preliminary Unaudited 2024 Revenue
04:10pm, Wednesday, 08'th Jan 2025
SAN DIEGO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovator
Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors
04:05pm, Thursday, 05'th Dec 2024
SAN DIEGO, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI), a global provider of life science reagents and services to researc
Maravai LifeSciences Announces November 2024 Investor Conference Schedule
08:05am, Tuesday, 12'th Nov 2024
SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to p
Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2024 Earnings Call Transcript
06:45pm, Saturday, 09'th Nov 2024
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI ) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Deb Hart - Head, Investor Relations Trey Martin - Chief Executive O
Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024
04:05pm, Tuesday, 15'th Oct 2024
SAN DIEGO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans t
